AAAAAA
Results:
1-14
|
Results: 14
Authors:
KETELHUT RG
MESSERLI FH
SCHOLZE J
Citation: Rg. Ketelhut et al., DOES CARDIAC FATIGUE CAUSE A DECREASE IN ARTERIAL-PRESSURE DURING LONG-TERM AEROBIC EXERCISE, Perfusion, 11(7), 1998, pp. 301
Authors:
SCHOLZE J
STAPFF M
Citation: J. Scholze et M. Stapff, START OF THERAPY WITH THE ANGIOTENSIN-II ANTAGONIST LOSARTAN AFTER IMMEDIATE SWITCH FROM PRETREATMENT WITH AN ACE-INHIBITOR, British journal of clinical pharmacology, 46(2), 1998, pp. 169-172
Authors:
SCHOLZE J
ZILLES P
COMPAGNONE D
Citation: J. Scholze et al., VERAPAMIL SR AND TRANDOLAPRIL COMBINATION THERAPY IN HYPERTENSION - ACLINICAL-TRIAL OF FACTORIAL DESIGN, British journal of clinical pharmacology, 45(5), 1998, pp. 491-495
Authors:
DORFFEL Y
LATSCH C
STUHLMULLER B
BURMESTER GR
SCHOLZE J
Citation: Y. Dorffel et al., ACTIVATED PERIPHERAL MONOCYTES IN ESSENTIAL-HYPERTENSION, Journal of hypertension, 16, 1998, pp. 516-516
Authors:
KETELHUT RG
FRANZ IW
SCHOLZE J
Citation: Rg. Ketelhut et al., EFFICACY AND POSITION OF ENDURANCE TRAINING AS A NONDRUG THERAPY IN THE TREATMENT OF ARTERIAL-HYPERTENSION, Journal of human hypertension, 11(10), 1997, pp. 651-655
Authors:
RUCKERT Y
HANSEN A
DORFFEL WV
ECKERT B
SCHOLZE J
Citation: Y. Ruckert et al., RESTRICTIVE CARDIOMYOPATHY DUE TO PRIMARY AMYLOIDOSIS AL, Zeitschrift fur Kardiologie, 86(10), 1997, pp. 812-817
Authors:
SCHOLZE J
Citation: J. Scholze, ABSTRACTS OF THE 19TH MEETING OF THE SCIENTIFIC SECTION OF THE GERMAN-HYPERTENSION-SOCIETY - 30 NOVEMBER 2 DECEMBER 1995, POTSDAM, Kidney & blood pressure research, 19(1), 1996, pp. 48-70
Authors:
SCHOLZE J
KLEIN G
Citation: J. Scholze et G. Klein, EQUIVALENT BLOOD-PRESSURE REDUCTION AND TOLERABILITY WITH CONTROLLED-RELEASE METOPROLOL 50MG ONCE-DAILY AND CONVENTIONAL METOPROLOL 50MG TWICE-DAILY - A DOUBLE-BLIND 8-WEEK COMPARISON IN HYPERTENSIVE PATIENTS, Clinical drug investigation, 11(6), 1996, pp. 331-338
Authors:
SCHOLZE J
Citation: J. Scholze, DEAR COLLEAGUES, Nieren- und Hochdruckkrankheiten, 25(10), 1996, pp. 491-491
Authors:
SCHOLZE J
Citation: J. Scholze, INTERVIEW WITH SCHOLZE,J. ON HYPERTENSION RESEARCH, Herz, Kreislauf, 28(5), 1996, pp. 3
Authors:
SCHOLZE J
Citation: J. Scholze, ANGIOTENSIN-II RECEPTOR ANTAGONISTS - CLI NICAL RELEVANCE, Der Internist, 37(6), 1996, pp. 636-642
Authors:
SCHOLZE J
Citation: J. Scholze, ACE-INHIBITORS AS FIRST-CHOICE AGENTS FOR THE MONOTHERAPY IN HYPERTENSION, Nieren- und Hochdruckkrankheiten, 24(1), 1995, pp. 12-15
Authors:
OVERLACK A
ADAMCZAK M
BACHMANN W
BONNER G
BRETZEL RG
DERICHS R
KRONE W
LEDERLE RM
REIMANN HJ
ZSCHIEDRICH H
STUMPE KO
CYRAN J
DIEHM C
FUCHS G
GOTZEN R
HEIMSOTH V
KNAUF H
KRONIG B
MAIER KE
MIDDEKE M
VONSANDEN H
SCHOLZE J
Citation: A. Overlack et al., ACE-INHIBITION WITH PERINDOPRIL IN ESSENTIAL HYPERTENSIVE PATIENTS WITH CONCOMITANT DISEASES, The American journal of medicine, 97(2), 1994, pp. 126-134
THERAPEUTIC SAFETY OF PERINDOPRIL IN THE TREATMENT OF MILD HYPERTENSION WITH CONCOMITANT NEPHROPATHY
Authors:
BONNER G
LEDERLE RM
SCHOLZE J
STUMPE KO
Citation: G. Bonner et al., THERAPEUTIC SAFETY OF PERINDOPRIL IN THE TREATMENT OF MILD HYPERTENSION WITH CONCOMITANT NEPHROPATHY, Arzneimittel-Forschung, 43-2(8), 1993, pp. 852-855
Risultati:
1-14
|